BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9377573)

  • 1. Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping.
    Coleman AE; Schröck E; Weaver Z; du Manoir S; Yang F; Ferguson-Smith MA; Ried T; Janz S
    Cancer Res; 1997 Oct; 57(20):4585-92. PubMed ID: 9377573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent non-reciprocal translocations of chromosome 5 in primary T(12;15)-positive BALB/c plasmacytomas.
    Coleman AE; Ried T; Janz S
    Curr Top Microbiol Immunol; 1999; 246():175-80; discussion 181. PubMed ID: 10396054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chromosome translocations and the activation of C-myc oncogene in mouse plasmacytomas].
    Ohno S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):587-96. PubMed ID: 6424577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice.
    Potter M; Mushinski EB; Wax JS; Hartley J; Mock BA
    Cancer Res; 1994 Feb; 54(4):969-75. PubMed ID: 8313388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomes 1 and 5 harbor plasmacytoma progressor genes in mice.
    Coleman AE; Ried T; Janz S
    Genes Chromosomes Cancer; 2000 Sep; 29(1):70-4. PubMed ID: 10918396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus.
    Wiener F; Coleman A; Mock BA; Potter M
    Cancer Res; 1995 Mar; 55(5):1181-8. PubMed ID: 7867005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific chromosome translocation in pristane-induced plasmacytomas of NZB mice.
    Oikawa T; Kuzumaki N; Yamada T
    J Natl Cancer Inst; 1984 Feb; 72(2):347-53. PubMed ID: 6582321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ig/myc translocations of the plasmacytoma-prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15.
    Silva S; Babonits M; Klein G
    Genes Chromosomes Cancer; 1996 Nov; 17(3):179-84. PubMed ID: 8946197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-myc-S mu rearrangement in a murine plasmacytoma without visible chromosomal translocations.
    Ohno S; Migita S; Murakami S
    Oncogene; 1989 Dec; 4(12):1513-7. PubMed ID: 2687771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation.
    McNeil N; Kim JS; Ried T; Janz S
    Genes Chromosomes Cancer; 2005 Jun; 43(2):137-46. PubMed ID: 15751044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extents.
    Shaughnessy JD; Owens JD; Wiener F; Hilbert DM; Huppi K; Potter M; Mushinski JF
    Oncogene; 1993 Nov; 8(11):3111-21. PubMed ID: 8414513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma.
    Shaughnessy J; Wiener F; Huppi K; Mushinski JF; Potter M
    Oncogene; 1994 Jan; 9(1):247-53. PubMed ID: 8302586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletional remodeling of c-myc-deregulating chromosomal translocations.
    Kovalchuk AL; Müller JR; Janz S
    Oncogene; 1997 Nov; 15(19):2369-77. PubMed ID: 9393881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice.
    Park SS; Shaffer AL; Kim JS; duBois W; Potter M; Staudt LM; Janz S
    Cancer Res; 2005 Sep; 65(17):7644-52. PubMed ID: 16140930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High resolution banding analysis of the involvement of strain BALB/c- and AKR-derived chromosomes No. 15 in plasmacytoma-specific translocations.
    Wiener F; Babonits M; Bregula U; Klein G; Léonard A; Wax JS; Potter M
    J Exp Med; 1984 Jan; 159(1):276-91. PubMed ID: 6607313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.
    Silva S; Wiener F; Klein G; Janz S
    Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal translocations deregulating c-myc are associated with normal immune responses.
    Roschke V; Kopantzev E; Dertzbaugh M; Rudikoff S
    Oncogene; 1997 Jun; 14(25):3011-6. PubMed ID: 9223664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E mu/S mu transposition into Myc is sometimes a precursor for T(12;15) translocation in mouse B cells.
    Kovalchuk AL; Kim JS; Janz S
    Oncogene; 2003 May; 22(18):2842-50. PubMed ID: 12743607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
    Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
    Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.